Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 11;13(9):e0203158.
doi: 10.1371/journal.pone.0203158. eCollection 2018.

Off-label use of ceftiofur in one-day chicks triggers a short-term increase of ESBL-producing E. coli in the gut

Affiliations

Off-label use of ceftiofur in one-day chicks triggers a short-term increase of ESBL-producing E. coli in the gut

Mauro M S Saraiva et al. PLoS One. .

Abstract

This trial was designed to evaluate the off-label use of ceftiofur with Marek's vaccine in one-day-old broiler chicks, a prophylactic treatment that has been done in some commercial hatcheries, on the emergence of extended-spectrum beta-lactamase producing Escherichia coli (ESBL-E. coli). A total of 168 chicks (Cobb500®) were used in a completely randomized design. Birds were assigned to two treatments (Marek's vaccine plus saline vs Marek's vaccine plus ceftiofur) and six repetitions, with 14 animals each. Cloacal swabs were collected from 1 to 14 days post-hatch. The majority (86%; p<0.0001) of the ESBL-producing isolates harboring blaCTX-M and blaSHV genes originated from animals receiving the antimicrobial. None of the isolates were positive for plasmid-mediated AmpC betalactamase genes (blaACC, blaCMY-2, blaDHA, blaFOX, blaMOX and blaMIR). These findings indicate that the off-label use of ceftiofur with Marek's vaccine is associated with the short-term increase in ESBL-producing Escherichia coli in the gut of chicks.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. ERIC-PCR genotyping of ESBL-E. coli cultured from broiler chick cloacal swabs.
Dendrogram showing the genotypic similarities among ESBL-positive E. coli by means of ERIC-PCR. Key = Identification of isolate; AG = antimicrobial-administered group—0.2mL (2 mg/L) of ceftiofur; CG = control group—0.2mL of saline solution.

References

    1. Baron S, Jouy E, Larvor E, Eono F, Bougeard S, Kempf I. Impact of third-generation-cephalosporin administration in hatcheries on fecal Escherichia coli antimicrobial resistance in broilers and layers. Antimicrob Agents Chemother. 2014. September 1;58(9):5428–34. 10.1128/AAC.03106-14 - DOI - PMC - PubMed
    1. Gibbons JF, Boland F, Egan J, Fanning S, Markey BK, Leonard FC. Antimicrobial resistance of faecal Escherichia coli isolates from pig farms with different durations of in-feed antimicrobial use. Zoonoses Public Health. 2016. May 1;63(3):241–50. 10.1111/zph.12225 - DOI - PubMed
    1. Collignon PC, Conly JM, Andremont A, McEwen SA, Aidara-Kane A, Agerso Y, et al. World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies to control antimicrobial resistance from food animal production. Clin Infect Dis. 2016. October 15;63(8):1087–93. 10.1093/cid/ciw475 - DOI - PubMed
    1. Webster P. The perils of poultry. CMAJ. 2009. July 7;181(1–2):21–4. 10.1503/cmaj.091009 - DOI - PMC - PubMed
    1. Dutil L, Irwin R, Finley R, Ng LK, Avery B, Boerlin P, et al. Ceftiofur resistance in Salmonella enterica serovar heidelberg from chicken meat and humans, Canada. Emerg Infect Dis. 2010. January 16(1):48–54. 10.3201/eid1601.090729 - DOI - PMC - PubMed

Publication types

MeSH terms